Ryan G.
About Ryan G.
Ryan G. is a Scientist at Bristol Myers Squibb with over 15 years of experience in academic and pharmaceutical industries, specializing in in vitro phenotypic and high throughput screening.
Current Role at Bristol Myers Squibb
Ryan G. currently holds the position of Scientist at Bristol Myers Squibb. Additionally, he serves as a Senior Associate Scientist in San Diego, California. His responsibilities likely include conducting research and contributing to the development of new therapeutic solutions, leveraging his extensive background in both in vitro and in vivo model development.
Previous Experience at Celgene
From 2017 to 2019, Ryan G. worked as a Scientist at Celgene in San Diego, California. During his tenure, he contributed to research initiatives likely focused on innovative treatments in various therapeutic areas. His role at Celgene helped further his expertise in high throughput screening and phenotypic assays.
Research Scientist at Regulus Therapeutics
Between 2012 and 2017, Ryan G. held the position of Research Scientist at Regulus Therapeutics. His work involved developing in vivo models and validating their efficacy, skills that are crucial in the pharmaceutical industry for drug development and testing. This role significantly contributed to his ability to transition from in vitro screening to in vivo proof-of-concept validation.
Educational Background
Ryan G. has a strong educational foundation in the sciences. He graduated from California State Polytechnic University with a BS in Microbiology and Chemistry, completing his studies between 1997 and 2003. Additionally, he obtained an Emergency Medical Technician certification from UCLA Prehospital Care in 2007. This blend of education supports his comprehensive skill set in both academic and pharmaceutical research.
Specialized Skills and Expertise
With over 15 years of experience, Ryan G. is specialized in in vitro phenotypic and high throughput screening. He is adept at developing in vivo models and validating their efficacy. His skills extend to taking potential targets from the in vitro screening stage to in vivo proof-of-concept validation, and he has been involved in translational studies crucial for IND submission. His broad expertise makes him a valuable asset in the pharmaceutical research field.